ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Pharma Equity Group A/s

Pharma Equity Group A/s (0REU)

0,40
0,00
(0,00%)
Geschlossen 27 November 5:30PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,40
Gebot
0,00
Fragen
0,00
Volumen
0,00
0,00 Tagesbereich 0,00
0,40 52-Wochen-Bereich 0,40
Marktkapitalisierung
Handelsende
0,40
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
0,00
Ausgegebene Aktien
1.022.964.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-16,60
Gewinn pro Aktie (EPS)
-0,02
Erlöse
-
Nettogewinn
-24,61M

Über Pharma Equity Group A/s

Sektor
Investors, Nec
Branche
Money Management
Hauptsitz
Copenhagen, Dnk
Gegründet
2002
Pharma Equity Group A/s is listed in the Investors sector of the Londoner Börse with ticker 0REU. The last closing price for Pharma Equity Group A/s was kr0,40. Over the last year, Pharma Equity Group A/s shares have traded in a share price range of kr 0,40 to kr 0,40.

Pharma Equity Group A/s currently has 1.022.964.000 shares in issue. The market capitalisation of Pharma Equity Group A/s is kr409,19 million. Pharma Equity Group A/s has a price to earnings ratio (PE ratio) of -16.60.

0REU Neueste Nachrichten

Consolidated Interim report 1 January – 30 September 2024

Consolidated Interim report 1 January – 30 September 2024 Consolidated Interim report 1 January – 30 September 2024 Company announcement no. 30 – November 15, 2024 Key points from the Q1-Q3-2024...

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.      Pharma Equity Group's...

Major shareholder announcement - Pharma Equity Group A/S

Major shareholder announcement - Pharma Equity Group A/S      Major shareholder announcement - Pharma Equity Group A/S 14 October 2024Announcement No. 28  Pharma Equity Group A/S has, in...

Managers’ transactions 

Managers’ transactions  October 14,2024Announcement no. 27 Managers’ transactions  Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014...

Pharma Equity Group announces successful completion of directed issue of new shares

Pharma Equity Group announces successful completion of directed issue of new shares      Pharma Equity Group announces successful completion of directed issue of new shares 11 October 2024Company...

Pharma Equity Group announces issuance of new shares in a direct issue

Pharma Equity Group announces issuance of new shares in a direct issue      Pharma Equity Group announces issuance of new shares in a direct issue  Inside information4 October 2024Company...

Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights

Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights      Registration of capital reduction by way of a...

Consolidated Interim Report 1 January – 30 June 2024

Consolidated Interim Report 1 January – 30 June 2024 Consolidated Interim Report 1 January – 30 June 2024 Company announcement no. 23 – August 16, 2024 Key points from the H1-2024 report (period 1...

The Board of Directors' decision to issue convertible loans

The Board of Directors' decision to issue convertible loans           The Board of Directors' decision to issue convertible loans     16 July 2024Company Announcement no. 22   The...

Major shareholder announcement - Pharma Equity Group A/S

Major shareholder announcement - Pharma Equity Group A/S           15 July 2024Announcement No. 21   Major shareholder announcement - Pharma Equity Group A/S   Pharma Equity Group...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.40.40.400DE
4000.40.40.400DE
12000.40.40.400DE
26000.40.40.400DE
52000.40.40.400DE
156000.40.40.400DE
260000.40.40.400DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ORCPOracle Power Plc
0,0305p
(158,47%)
6,24B
STKStreaksai Plc
0,35p
(59,09%)
8,58M
QEDQuadrise Plc
3,62p
(57,39%)
94,06M
ENWEnwell Energy Plc
23,00p
(46,03%)
160,81k
WEBWebis Holdings Plc
0,125p
(38,89%)
9,14M
INXI-nexus Global Plc
1,50p
(-52,38%)
7,25M
SFRSeverfield Plc
55,60p
(-36,24%)
9,71M
LENDSancus Lending Group Limited
0,30p
(-33,33%)
1,23M
TRYBTribe Technology Plc
2,45p
(-20,97%)
80k
GWMOGreat Western Mining Corporation Plc
0,0175p
(-20,45%)
169,92M
ORCPOracle Power Plc
0,0305p
(158,47%)
6,24B
NTVONativo Resources Plc
0,0025p
(0,00%)
3,46B
TRPTower Resources Plc
0,0275p
(0,00%)
526,88M
CPXCap-xx Limited
0,145p
(-13,43%)
499,92M
MSMNMosman Oil And Gas Limited
0,038p
(-1,30%)
329,43M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht